Related Experiment Videos
Evaluation of Ehrlich's test as screening test for cancer
1Department of Biochemistry, B.L.D.E.A's Medical College, Bijapur.
Indian Journal of Medical Sciences
|November 1, 1992
Summary
Ehrlich's test, serum mucoproteins, phosphohexoisomerase (PHI), and lactate dehydrogenase (LDH) are elevated in cancer patients. Ehrlich's test shows promise as a superior cancer screening method, potentially linked to serum mucoproteins.
Area of Science:
- Biochemistry
- Oncology
- Clinical Diagnostics
Background:
- Cancer diagnosis relies on various biomarkers.
- Evaluating the efficacy of existing diagnostic tests is crucial for early detection.
- Serum mucoproteins, PHI, and LDH are potential indicators in cancer.
Purpose of the Study:
- To compare the levels of Ehrlich's test, serum mucoproteins, PHI, and LDH in cancer patients versus controls.
- To assess the validity of Ehrlich's test, PHI, and LDH as cancer screening tools.
- To investigate the relationship between serum mucoproteins and Ehrlich's test results.
Main Methods:
- Comparative analysis of biochemical markers.
- Patient cohort study with age-matched controls.
- Statistical evaluation of diagnostic test performance.
Main Results:
- Significantly elevated levels of Ehrlich's test, serum mucoproteins, PHI, and LDH were observed in cancer patients.
- Ehrlich's test demonstrated superior performance as a cancer screening test compared to PHI and LDH.
- A positive correlation was found between serum mucoproteins and Ehrlich's test.
Conclusions:
- Ehrlich's test is a potentially valuable screening tool for cancer detection.
- Serum mucoproteins may play a role in the colorimetric reaction of Ehrlich's test.
- Further research is warranted to validate these findings in larger populations.